Evidence map›Paper›PMID 25336731›Full record

ArticleThe Journal of infectious diseases2015

Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.

Xiao-Song He, Tyson H Holmes, Mrinmoy Sanyal, Randy A Albrecht, Adolfo García-Sastre, Cornelia L Dekker, Mark M Davis, Harry B Greenberg

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02141581 phase4completednot on this map

Vaccination and Infection: Indicators of Immunological Health and Responsiveness. Project 1: Plasmablast Trafficking and Antibody Response in Influenza Vaccination;

TypeinterventionalSponsorStanford UniversityRan2011 to 2014Enrolled86ConditionsInfluenzaArmsFluzone® (IM), Fluzone® Intradermal (ID), 2011-2012 FluMist®
NCT03020498 phase4completednot on this map

Protective Mechanisms Against a Pandemic Respiratory Virus. Project 1: B-cell Immunity to Influenza. Technical Development Project 1: Measuring the Immunome: Genomic Approaches to B-cell Repertoire - Years 2 (2010) & 3 (2011)

TypeinterventionalSponsorStanford UniversityRan2010 to 2011Enrolled91ConditionsInfluenzaArmsFluzone, FluMist
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Influenza in Children.Cold Spring Harbor perspectives in medicine · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Diminished B-Cell Response After Repeat Influenza Vaccination.The Journal of infectious diseases · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Immunity to influenza. Preventing infection and regulating disease.American journal of respiratory and critical care medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Xiao-Song HeDepartment of Medicine VA Palo Alto Health Care System, California.
Tyson H HolmesDepartment of Psychiatry and Behavioral Sciences.
Mrinmoy SanyalDepartment of Medicine VA Palo Alto Health Care System, California.
Randy A AlbrechtDepartment of Microbiology, Global Health and Emerging Pathogens Institute.
Adolfo García-SastreDepartment of Microbiology, Global Health and Emerging Pathogens Institute Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York.
Cornelia L DekkerDepartment of Pediatrics.
Mark M DavisDepartment of Microbiology and Immunology Institute for Immunity, Transplantation, and Infection Howard Hughes Medical Institute, Stanford University School of Medicine.
Harry B GreenbergDepartment of Medicine Department of Microbiology and Immunology VA Palo Alto Health Care System, California.
VA Palo Alto Health Care System · USHoward Hughes Medical Institute · USIcahn School of Medicine at Mount Sinai · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Toward a Universal Influenza Virus VaccineP01AI097092 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2012 to 2022
$17.6M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2010 to 2015
$17.3M
Vaccine Induced Activation of T Follicular Helper Cell SubsetsU19AI089987 · NIAID · BAYLOR RESEARCH INSTITUTE · PI PASCUAL, MARIA VIRGINIA · 2010 to 2015
$17.0M
NCATS NIH HHS UL1 TR001085NCRR NIH HHS UL1 RR025744NCRR NIH HHS UL1RR025744NIAID NIH HHS AI057229NIAID NIH HHS AI089987NIAID NIH HHS AI090019NIAID NIH HHS HHSN272201400008CNIAID NIH HHS P01 AI097092NIAID NIH HHS P01AI097092NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI089987NIAID NIH HHS U19AI089987NIAID NIH HHS U19 AI090019
6 · The paper itself

Abstract

backgroundThe human B-cell response to natural influenza virus infection has not been extensively investigated at the polyclonal level.

methodsThe overall B-cell response of patients acutely infected with the 2009 pandemic influenza A(H1N1)pdm09 virus (A[H1N1]pdm09) was analyzed by determining the reactivity of plasmablast-derived polyclonal antibodies (PPAbs) to influenza proteins. Recipients of inactivated influenza vaccine containing the same A(H1N1)pdm09 strain were studied for comparison.

resultsDuring acute infection, robust plasmablast responses to the infecting virus were detected, characterized by a greater PPAb reactivity to the conserved influenza virus nuclear protein and to heterovariant and heterosubtypic hemagglutinins, in comparison to responses to the inactivated A(H1N1)pdm09 vaccine. In A(H1N1)pdm09 vaccinees, the presence of baseline serum neutralizing antibodies against A(H1N1)pdm09, suggesting previous exposure to natural A(H1N1)pdm09 infection, did not affect the plasmablast response to vaccination, whereas repeated immunization with inactivated A(H1N1)pdm09 vaccine resulted in significantly reduced vaccine-specific and cross-reactive PPAb responses.

conclusionsNatural A(H1N1)pdm09 infection and inactivated A(H1N1)pdm09 vaccination result in very distinct patterns of B-cell activation and priming. These differences are likely to be associated with differences in protective immunity, especially cross-protection against heterovariant and heterosubtypic influenza virus strains.

Indexed as

VaccinationAdolescentAdultAgedAntibodies, NeutralizingAntibodies, ViralB-LymphocytesCross ProtectionCross ReactionsFemaleHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesLymphocyte ActivationMaleAntibodies, NeutralizingAntibodies, ViralInfluenza VaccinesVaccines, InactivatedantibodyB-cell responseinfluenza vaccineinfluenza virus infectionplasmablast

Identifiers

PMID25336731
PMCPMC4366605
OpenAlexW2118140970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.